Gene: CDK5R1
Official Full Name: cyclin dependent kinase 5 regulatory subunit 1provided by HGNC
Gene Summary: The protein encoded by this gene (p35) is a neuron-specific activator of cyclin-dependent kinase 5 (CDK5); the activation of CDK5 is required for proper development of the central nervous system. The p35 form of this protein is proteolytically cleaved by calpain, generating a p25 form. The cleavage of p35 into p25 results in relocalization of the protein from the cell periphery to nuclear and perinuclear regions. P25 deregulates CDK5 activity by prolonging its activation and changing its cellular location. The p25 form accumulates in the brain neurons of patients with Alzheimer's disease. This accumulation correlates with an increase in CDK5 kinase activity, and may lead to aberrantly phosphorylated forms of the microtubule-associated protein tau, which contributes to Alzheimer's disease. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO33789 | CDK5R1 Knockout cell line (HeLa) | Human | CDK5R1 | 1:3~1:6 | Negative | Online Inquiry |
KO33790 | CDK5R1 Knockout cell line (HCT 116) | Human | CDK5R1 | 1:2~1:4 | Negative | Online Inquiry |
KO33791 | CDK5R1 Knockout cell line (HEK293) | Human | CDK5R1 | 1:3~1:6 | Negative | Online Inquiry |
KO33792 | CDK5R1 Knockout cell line (A549) | Human | CDK5R1 | 1:3~1:4 | Negative | Online Inquiry |
CDK5R1 Gene Knockout Cell Lines represent a pivotal advancement in molecular biology research, providing a versatile model for studying the cyclin-dependent kinase 5 (CDK5) pathway's role in neuronal function and various neurological disorders. These cell lines have been genetically engineered to disrupt the CDK5R1 gene, which encodes for the cyclin-dependent kinase 5 regulatory subunit 1. The knockout mechanism is accomplished through established gene-editing technology, allowing researchers to elucidate the gene's involvement in cell cycle regulation, apoptosis, and synaptic plasticity.
The primary function of these knockout cell lines is to facilitate in-depth exploration of the CDK5 signaling cascade's implications in neurodegenerative diseases, such as Alzheimer’s and Parkinson’s disease. By employing these models, researchers can investigate the downstream effects of CDK5 dysregulation on neuronal survival and activity, thus shedding light on potential therapeutic targets. Additionally, these cell lines serve as critical tools in drug discovery, enabling the assessment of pharmacological agents' efficacy in modulating CDK5-related pathways.
In comparison to traditional cell culture models, CDK5R1 Gene Knockout Cell Lines provide unique advantages, including enhanced specificity in the context of CDK5 interactions and more accurate mimicking of pathophysiological conditions. They are invaluable for their potential to yield reproducible results that are critical for advancing both basic and applied biomedical research.
With the growing focus on personalized medicine and targeted therapies, the implications of understanding CDK5 functions have never been more significant. Our company excels in delivering high-quality biological products, backed by rigorous scientific validation and expertise, ensuring that researchers and clinicians have access to the most reliable models to drive innovation and improve patient outcomes. Through our commitment to advancing the field, we empower scientific discovery with tools that unlock new possibilities.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.